Suppr超能文献

血小板前体细胞可从培养的人CD34+祖细胞中生成,但在小鼠体内输血后会重新循环进入造血组织。

Platelet Precursor Cells Can Be Generated from Cultured Human CD34+ Progenitor Cells But Display Recirculation into Hematopoietic Tissue upon Transfusion in Mice.

作者信息

Hintze Christian, Rüster Brigitte, Seifried Erhard, Henschler Reinhard

机构信息

Institut für Transfusionsmedizin und Immunhämatologie, DRK Blutspendedienst, Johann Wolfgang Goethe Universität Frankfurt, Germany.

出版信息

Transfus Med Hemother. 2010;37(4):185-190. doi: 10.1159/000316975. Epub 2010 Jul 14.

Abstract

BACKGROUND

Whereas ex vivo expanded megakaryocytic progenitor cells have been investigated for their ability to support platelet regeneration, the question whether more mature platelet-like particles expanded from hematopoietic progenitor cells may be useful for transfusion purposes remains largely elusive. METHODS: Human peripheral blood progenitor cells (PBPCs) were enriched using surface expression of CD34 by immunoselection. CD34+ enriched PBPCs were expanded ex vivo in serum-free medium supplemented with cytokines. As a proof-of-principle, distribution of expanded CD61+ particles was analyzed after transfusion into Non-Obese Diabetic/ Severe Combined Immunodeficiency (NOD/SCID) mice. RESULTS: Highest ex vivo expansion for CD41+/CD61 + cells was achieved when medium was supplemented with SCF, TPO and IL-3. During expansion culture, CD34 marker expression decreased from 85 to 2-8%, while megakaryocytic cells appeared and CD41 and CD61 expression increased from 3 to about 30%. After transfusion of the expanded cells in NOD/SCID mice, CD61 + cells located mainly to bone marrow and to a lesser degree to spleen, but also circulated in blood. CONCLUSIONS: Platelet-like particles using cytokine-substituted serumfree medium can be generated efficiently from CD34+ expansion cultures, but mainly home to hematopoietic tissue.

摘要

背景

尽管已对体外扩增的巨核细胞祖细胞支持血小板再生的能力进行了研究,但从造血祖细胞扩增而来的更成熟的血小板样颗粒是否可用于输血目的这一问题在很大程度上仍不清楚。

方法

通过免疫选择利用CD34的表面表达富集人外周血祖细胞(PBPCs)。将富集了CD34+的PBPCs在补充有细胞因子的无血清培养基中进行体外扩增。作为原理验证,在将扩增后的CD61+颗粒输注到非肥胖糖尿病/严重联合免疫缺陷(NOD/SCID)小鼠体内后,分析其分布情况。

结果

当培养基中添加干细胞因子(SCF)、血小板生成素(TPO)和白细胞介素-3(IL-3)时,CD41+/CD61 +细胞实现了最高的体外扩增。在扩增培养过程中,CD34标志物表达从85%降至2 - 8%,同时出现了巨核细胞,CD41和CD61表达从3%增加至约30%。将扩增后的细胞输注到NOD/SCID小鼠体内后,CD61 +细胞主要定位于骨髓,在脾脏中的定位较少,但也在血液中循环。

结论

使用细胞因子替代的无血清培养基可从CD34+扩增培养物中高效生成血小板样颗粒,但主要归巢于造血组织。

相似文献

本文引用的文献

3
New strategies for the optimal use of platelet transfusions.血小板输注最佳使用的新策略。
Hematology Am Soc Hematol Educ Program. 2008:198-204. doi: 10.1182/asheducation-2008.1.198.
7
From hematopoietic stem cells to platelets.从造血干细胞到血小板。
J Thromb Haemost. 2007 Jul;5 Suppl 1:318-27. doi: 10.1111/j.1538-7836.2007.02472.x.
9
Mechanics of proplatelet elaboration.前血小板形成的机制。
J Thromb Haemost. 2007 Jul;5 Suppl 1:18-23. doi: 10.1111/j.1538-7836.2007.02487.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验